Stellate Ganglion Block to Treat Long COVID 19 Case Series

NCT05812209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2023-04-13

No results posted yet for this study

Summary

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Conditions

Interventions

PROCEDURE

Stellate Ganglion Block

Ultrasound guided block of the Stellate Ganglion with local anesthetics.

Sponsors & Collaborators

  • Metamorphosis LTD

    lead OTHER

Principal Investigators

  • Lisa Pearson, DNAP · Metamorphosis LTD

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05812209 on ClinicalTrials.gov